rs145668843
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 2P and 14B. PM1BP4_ModerateBP6_Very_StrongBS2
The NM_004006.3(DMD):āc.696C>Gā(p.Ile232Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000359 in 1,207,499 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 132 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00022 ( 0 hom., 4 hem., cov: 23)
Exomes š: 0.00037 ( 0 hom. 128 hem. )
Consequence
DMD
NM_004006.3 missense
NM_004006.3 missense
Scores
9
7
Clinical Significance
Conservation
PhyloP100: 2.51
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
PM1
In a region_of_interest Actin-binding (size 239) in uniprot entity DMD_HUMAN there are 5 pathogenic changes around while only 1 benign (83%) in NM_004006.3
BP4
Computational evidence support a benign effect (MetaRNN=0.24008453).
BP6
Variant X-32699247-G-C is Benign according to our data. Variant chrX-32699247-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 284717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-32699247-G-C is described in Lovd as [Likely_benign].
BS2
High Hemizygotes in GnomAd4 at 4 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMD | NM_004006.3 | c.696C>G | p.Ile232Met | missense_variant | 8/79 | ENST00000357033.9 | NP_003997.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMD | ENST00000357033.9 | c.696C>G | p.Ile232Met | missense_variant | 8/79 | 1 | NM_004006.3 | ENSP00000354923 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000215 AC: 24AN: 111607Hom.: 0 Cov.: 23 AF XY: 0.000118 AC XY: 4AN XY: 33839
GnomAD3 genomes
AF:
AC:
24
AN:
111607
Hom.:
Cov.:
23
AF XY:
AC XY:
4
AN XY:
33839
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000224 AC: 41AN: 182849Hom.: 0 AF XY: 0.000237 AC XY: 16AN XY: 67575
GnomAD3 exomes
AF:
AC:
41
AN:
182849
Hom.:
AF XY:
AC XY:
16
AN XY:
67575
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000374 AC: 410AN: 1095892Hom.: 0 Cov.: 29 AF XY: 0.000354 AC XY: 128AN XY: 361506
GnomAD4 exome
AF:
AC:
410
AN:
1095892
Hom.:
Cov.:
29
AF XY:
AC XY:
128
AN XY:
361506
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000215 AC: 24AN: 111607Hom.: 0 Cov.: 23 AF XY: 0.000118 AC XY: 4AN XY: 33839
GnomAD4 genome
AF:
AC:
24
AN:
111607
Hom.:
Cov.:
23
AF XY:
AC XY:
4
AN XY:
33839
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
25
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 24, 2019 | This variant is associated with the following publications: (PMID: 26392559) - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 09, 2017 | The p.Ile232Met variant (rs145668843) has not been reported in the medical literature, gene specific variation databases, nor has it been previously identified by our laboratory. This variant is listed in the Genome Aggregation Database (gnomAD) with an overall population frequency of 0.02 percent (identified on 40 out of 199,721 chromosomes, including 17 hemizygotes), and has been reported to the ClinVar database as a likely benign variant (Variation ID: 284717). The isoleucine at position 232 is moderately conserved considering 7 species (Alamut v2.10) and computational analyses of the p.Ile232Met variant on protein structure and function indicate a neutral effect (GVGD: class C0, MutationTaster: polymorphism, PolyPhen-2: benign). Overall this variant is considered to be likely benign. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 03, 2016 | - - |
Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 21, 2017 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 14, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Duchenne muscular dystrophy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 17, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
.;D;.;.;D
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;.;T;T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Uncertain
D
MutationTaster
Benign
N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
.;N;.;N;N
REVEL
Uncertain
Sift
Uncertain
.;D;.;D;D
Sift4G
Uncertain
D;D;D;D;D
Polyphen
0.046, 0.0020
.;B;.;.;B
Vest4
MVP
MPC
0.021
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at